CA Stock MarketDetailed Quotes
MYND MYND Life Sciences Inc
- 0.100
- +0.030+42.86%
15min DelayTrading Dec 23 10:07 ET
4.78MMarket Cap-5.00P/E (TTM)
0.100High0.095Low5.00KVolume0.095Open0.070Pre Close485.00Turnover0.14052wk High0.02%Turnover Ratio47.82MShares0.01052wk Low-0.02EPS TTM3.32MFloat Cap2.500Historical HighLossP/E (Static)33.24MShs Float0.005Historical Low-0.03EPS LYR7.14%Amplitude--Dividend TTM-0.80P/B1Lot Size--Div YieldTTM
MYND Life Sciences Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | (Q3)Jul 31, 2023 | (Q2)Apr 30, 2023 | (Q1)Jan 31, 2023 | (FY)Oct 31, 2022 | (Q4)Oct 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --1 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | 0.00%60K | 0.00%60K | 0.00%60K | 33.33%240K | 0.00%60K | -50.00%60K | 60K | 60K | 180K | 60K |
| Gross profit | 0.00%-60K | 0.00%-60K | 0.00%-60K | -33.33%-240K | 0.00%-60K | 50.00%-60K | -60K | -60K | -180K | -30.61%-60K |
| Operating expense | 10.74%281.77K | -61.62%161.23K | -53.14%274.43K | -44.90%1.59M | -26.70%328.55K | -54.78%254.44K | -41.42%420.13K | -49.63%585.65K | -32.82%2.88M | -69.09%448.19K |
| Selling and administrative expenses | 3.89%221.74K | -67.94%128.42K | -74.94%112.12K | -21.76%1.19M | 32.21%123.8K | -14.50%213.44K | 20.47%400.55K | -47.15%447.32K | -50.68%1.51M | -88.75%93.64K |
| -Selling and marketing expense | -94.00%636 | -53.24%11.41K | -99.20%2.52K | 165.91%362.07K | -53.83%12.07K | -51.59%10.6K | -45.98%24.4K | 633.22%315K | -66.75%136.16K | -93.62%26.14K |
| -General and administrative expense | 9.00%221.1K | -68.89%117.01K | -17.16%109.61K | -40.29%823.05K | 65.52%111.74K | -10.93%202.84K | 30.92%376.16K | -83.53%132.32K | -48.21%1.38M | -84.04%67.51K |
| Research and development costs | --0 | --0 | 51.23%151.23K | -76.13%282.28K | -39.24%182.28K | --0 | --0 | -64.02%100K | 9.60%1.18M | -47.68%300K |
| Depreciation amortization depletion | -90.80%82 | -91.69%653 | -94.24%653 | -64.92%20.99K | -92.33%892 | -92.34%891 | -47.46%7.86K | -47.53%11.34K | -30.53%59.83K | -61.17%11.63K |
| -Depreciation and amortization | -90.80%82 | -91.69%653 | -94.24%653 | -64.92%20.99K | -92.33%892 | -92.34%891 | -47.46%7.86K | -47.53%11.34K | -30.53%59.83K | -61.17%11.63K |
| Other operating expenses | 49.47%59.95K | 174.39%32.16K | -61.34%10.43K | -20.49%100.39K | -49.74%21.57K | 154.51%40.11K | -76.94%11.72K | 61.18%26.98K | 128.89%126.26K | 202.14%42.93K |
| Operating profit | -8.69%-341.77K | 53.92%-221.23K | 48.20%-334.43K | 40.30%-1.83M | 23.54%-388.55K | 53.94%-314.44K | 33.06%-480.13K | 44.47%-645.65K | 28.62%-3.06M | 66.03%-508.19K |
| Net non-operating interest income (expenses) | 82.67%-37.5K | 80.66%-38.33K | 80.13%-38.33K | -10.39%-731.76K | 31.21%-124.26K | -27.85%-216.36K | -26.75%-198.24K | -23.15%-192.9K | -391.47%-662.91K | -93.24%-180.64K |
| Non-operating interest expense | -82.67%37.5K | -80.66%38.33K | -80.13%38.33K | 10.39%731.76K | -31.21%124.26K | 27.85%216.36K | 26.75%198.24K | 23.15%192.9K | 391.47%662.91K | 93.24%180.64K |
| Other net income (expenses) | 3,504.20%1.04M | 16,274.97%981.84K | 21 | 316.45%60.75K | -99.44%47 | 126.53%28.93K | 6K | |||
| Special income (charges) | --0 | --0 | ---- | 6,768.96%999.3K | --981.84K | --0 | 19.98%17.45K | ---- | 113.34%14.55K | --0 |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | -19.98%-17.45K | ---- | ---14.55K | --0 |
| -Gain on sale of business | ---- | ---- | ---- | --999.3K | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non-operating income (expenses) | ---- | ---- | ---- | 201.52%43.36K | -99.98%1 | --21 | 110,907.69%43.29K | -99.44%47 | --14.38K | --6K |
| Income before tax | 28.54%-379.27K | 57.97%-259.56K | 55.54%-372.76K | 58.95%-1.52M | 168.69%469.04K | 37.69%-530.78K | 28.10%-617.62K | 36.04%-838.5K | 18.48%-3.7M | 59.79%-682.84K |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 22.79%-129.95K | 17.90%-129.95K | ||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 28.54%-379.27K | 57.97%-259.56K | 55.54%-372.76K | 57.45%-1.52M | 184.83%469.04K | 37.69%-530.78K | 28.10%-617.62K | 36.04%-838.5K | 18.32%-3.57M | 64.10%-552.89K |
| Net income continuous operations | 28.54%-379.27K | 57.97%-259.56K | 55.54%-372.76K | 57.45%-1.52M | 184.83%469.04K | 37.69%-530.78K | 28.10%-617.62K | 36.04%-838.5K | 18.32%-3.57M | 64.10%-552.89K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 28.54%-379.27K | 57.97%-259.56K | 55.54%-372.76K | 57.45%-1.52M | 184.83%469.04K | 37.69%-530.78K | 28.10%-617.62K | 36.04%-838.5K | 18.32%-3.57M | 84.60%-552.89K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 28.54%-379.27K | 57.97%-259.56K | 55.54%-372.76K | 57.45%-1.52M | 184.83%469.04K | 37.69%-530.78K | 28.10%-617.62K | 36.04%-838.5K | 18.32%-3.57M | 84.60%-552.89K |
| Diluted earnings per share | 0.00%-0.01 | 50.00%-0.01 | 50.00%-0.01 | 62.50%-0.03 | 150.00%0.01 | 50.00%-0.01 | 0.00%-0.02 | 33.33%-0.02 | 20.00%-0.08 | 50.00%-0.02 |
| Basic earnings per share | 0.00%-0.01 | 50.00%-0.01 | 50.00%-0.01 | 62.50%-0.03 | 150.00%0.01 | 50.00%-0.01 | 0.00%-0.02 | 33.33%-0.02 | 20.00%-0.08 | 50.00%-0.02 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Price
% Chg
No Data